chapter 43 antidiabetic drugs revised 11/10. diabetes a complicated, chronic disorder characterized...

112
Chapter 43 Antidiabetic Drugs Revised 11/10

Upload: sharyl-kennedy

Post on 27-Jan-2016

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Chapter 43

Antidiabetic DrugsRevised 11/10

Page 2: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Diabetes

A complicated, chronic disorder characterized by insufficient

insulin production or by cellular resistance to insulin

Page 3: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Two Types of Diabetes Type 1—insulin-

dependent diabetes mellitus (IDDM)

Insulin produced in insufficient amounts

Requires insulin

Type 2—non-insulin-dependent diabetes mellitus (NIDDM)

Decreased production of insulin or decreased cell sensitivity to insulin

May be treated with oral drug and/or insulin

Page 4: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Four Pillars of Management of Diabetes

Meal planning referred to as medical nutrition therapy

Activity and exercise Medication Self monitoring of blood glucose

(SMBG)

Page 5: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin

A hormone produced by the pancreas that acts to maintain

blood glucose levels within normal limits

Insulin is a high alert medication

Page 6: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin

Essential for the use of glucose in cellular metabolism and for proper

protein and fat metabolism

Page 7: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin A hormone produced by the beta cells

of the pancreas Controls the use of glucose, protein, and

fat in the body Lowers blood sugar by inhibiting

glucose production by the liver FA Davis, FON, onset, peaks, duration.

See handout from pharm 1 (corrections made)

Page 8: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular
Page 9: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Available as purified extracts from

beef and pork pancreas (used infrequently)

Synthetic insulins, such a human insulin and insulin analogs;derived from strains of Escherichia coli (recombinant DNA), fewer allergies with this than extracts of beef and pork

Activates a process that helps glucose molecules enter the cells

Stimulates the liver glycogen synthesis

Page 10: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin (Con’t)

Used to treat diabetes mellitus and control more severe and complicated forms of type 2 diabetes

Page 11: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular
Page 12: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Injections:

Must be injected into the subcutaneous in the legs, arms, stomachs or buttocks. Cannot be taken orally- it’s a protein and the stomach acid would break it down before it could be used.

Newer forms include Insulin Pump

Page 13: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

ADMINISTERING INSULIN BY INJECTION

Administered with an insulin syringe ( syringe calibrated in units)

Various insulin syringes hold volumes of 0.3, 0.5, and 1 mL

The standard dosage strength of insulin is 100 U/mL

Low dose insulin syringes are used to deliver insulin in 30-50 U or less

A standard insulin syringe can administer up to 100 U of insulin

Page 14: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular
Page 15: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Syringe Size is ½ inch

Page 16: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Preparations See handout from Introduction to

Pharmacology Text, page 411

New insulin Levemir (similar to Lantus, cannot mix with other insulins)

Considered a basal insulin like NPH and Lantus (covers the body’s basal metabolic needs in the absence of food)

Page 17: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Onset, Peak, and Duration of Action Define onset, peak and duration Refer to Handout from Introduction to

Pharmacology Text, page 411, must memorize onset,

peak and duration of each type of insulin (review of introduction to pharmacology)

Hypoglycemia reactions can occur anytime but most common during peak (treat with OJ, hard candy, glucose tabs, glucagon, Glucose 10% & 50% IV). Make sure patient has swallowing and gag reflexes for po method)

Page 18: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Contraindications

Contraindicated if patient has hypersensitivity to any ingredient in the product (older preparations made with beef and pork) and if the patient is hypoglycemic

Page 19: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Precautions

Used cautiously with renal and hepatic impairment and during pregnancy and lactation

Page 20: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Interactions

See Display 43-1 Drugs that Decrease and Increase the Hypoglycemic Effect of Insulin, page 412

Include as nursing considerations Also review on page 412 signs and

symptoms of hypoglycemia and hyperglycemia

Page 21: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drugs that Decrease the Hypoglycemic Effect of Insulin AIDS antivirals Albuterol Contraceptives Corticosteroids Estrogens Diuretics Epinephrine Thyroid hormones

Page 22: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drugs that Increase the Hypoglycemic Effect of Insulin Alcohol Ace inhibitors Oral antidiabetic drugs Calcium Clonidine Lithium MAOIs Salicylate Sulfonimides Tetracycline

Page 23: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

MIXING INSULINS

Insulins tend to bind and become equilibrated

Inject within 5 minutes of mixing Regular which is additive free, is

combined with intermediate-acting insulin such as Humulin

Page 24: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Mixing Insulins

Page 25: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Promoting Optimal Response to Insulin Therapy

Will be individualized Expect adjustments when under

stress and with any illness, particularly illnesses resulting in nausea and vomiting

Page 26: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Examples of Insulin Administration using a Sliding Scale Handout from Morton Hospital (use

as an example) Double sided (reverse has how to

treat hypoglycemia) Follow agency protocol

Page 27: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Preparing Insulin for Administration Current insulin bottle at room

temperature, except Lantus which is refrigerated

Check expiration (dated at time of opening and used for a one month period)

Do not shake, rotate gently, invert gently for those insulins in suspension

Page 28: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Rotating Injection Sites Rotating sites prevents lipodystrophy

(atrophy of subcutaneous fat) Lipodystrophy interferes with absorption of

insulin Appears as a slight dimpling or pitting of SC

fat Ask patient about particular site rotation

schedule Newer philosophy involves using all sites in

one area before moving to another body part See text, page 551

Page 29: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Body Diagram of Appropriate Sites

Page 30: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Methods of Administering Insulin

Parenteral-subcutaneous or intravenous

Insulin Pump Inhalation- research continues,

Exubria (Pfizer) taken off market, Dec. 2008 due to risks with lungs/complications

Page 31: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Pumps Newer technology. Attempts to mimic

the body’s normal pancreatic function. Only regular insulin is used. Needle inserted subcutaneously and left

in place for 1-3 days Battery operated. Amount of insulin injected can be

adjusted according to blood glucose levels (monitored 4-8 times a day)

Page 32: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Inhaled Insulin- Recently taken off market- only FYI

Food and Drug Administration approved the first noninjectable insulin in a dry inhalation powder in early 2006 (Exubera)

Exubera was a rapid acting insulin and must be taken within 10 minutes of a meal. Peaks 90-120 minutes similar to rapid acting analogs (Humalog, Novolog, Apidra). Duration was 6 hours.

Contraindicated in people who smoke or recently stopped within 6 months, or poorly controlled lung disease, and during pregnancy.

Dosing- not supplied in international units, rather 1 mg or 3 mg blisters. (1 mg blister equivalent to 3 units; 3 mg blister equivalent to 8 units (physics/ cloud burst)

Directions: load, apply pressure, inhale, hold breath for 5 seconds at the end of inhalation.

Page 33: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Monitoring and Managing Adverse Reactions

Must know signs and symptoms of hypoglycemia and hyperglycemia

Page 34: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Signs of Hyperglycemia 3 Ps- polyuria, polydipsia, polyphagia Blurred vision Fatigue, lethargy, drowsiness Headache Abdominal pain Dry, flushed, warm skin Ketonuria Acetone breath (fruity odor due to ketones) Rapid, weak pulse Coma

Page 35: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Signs of Hypoglycemia Headache Hunger Fight or flight

Shaky Cold sweat (cool, clammy skin, diaphoresis) “Cold and clammy, need some candy” Palpitations Tachycardia

Neuroglycopenia Irritability, nervousness, anxiety Confusion Blurred vision General weakness Drowsiness Seizures, coma

CAUTION Autonomic neuropathy: No symptoms

Page 36: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Educating the Patient and Family Review principles of teaching the adult patient Noncompliance may be a problem with some

patients (may be related to lack of understanding of disease process or medications or management)

Establish a thorough teaching plan for patients newly diagnosed, for patients with changes in treatment plan

Include teaching on diet, glucose monitoring, medications, adverse reactions, hygiene, exercise, sick day protocols, medic alert bracelets

Page 37: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Nursing Diagnoses

Anxiety and Fear Impaired Adjustment, Coping, and

Altered Health Maintenance Acute confusion related to

hypoglycemic reaction Glucose, risk for instable blood

glucose

Page 38: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Oral Drugs Sulfonylureas Biguanides Alpha-glucosidase inhibitors Meglitinides Thiazolidinediones Hormone Mimetic Agents –many different

actions to help lower blood sugar levels, see page 424; Januvia, Byetta, Symlin

See Summary of Drugs- pages 556-557 Sometimes oral antidiabetic drugs are used

in combinations

Page 39: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Sulfonylureas Examples—tolbutamide (Orinase), glipizide (Glucotrol),

glyburide (Diabeta, Micronase), glimepiride (Amaryl) Act to lower blood glucose by stimulating the beta cell to

release insulin Adverse Reactions—hypoglycemia, anorexia, nausea,

vomiting, epigastric discomfort, weight gain, heartburn, weakness and numbness of extremities

Nursing considerations:Glucotrol given 30 minutes before a meal, glyburide is given with breakfast. Avoid alcohol (has a disulfiram-like reaction(Antabuse)-flushing, throbbing in head and neck, respiratory difficulty, vomiting, sweating, chest pain and hypotension, arrhythmias, and unconsciousness

Secondary failure may occur (may lose effectiveness,; may prescribe another sulfonylureas or add another oral antidiabetic drug such as metformin

Page 40: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Biguanides Example—metformin (Glucophage) Action—reduces hepatic glucose production and

increases insulin sensitivity to muscle and fat cells. May cause weight loss, favorable SE includes lowering of triglycerides and LDL cholesterol

Adverse Reactions—gastrointestinal (GI) upset (abdominal bloating, nausea, cramping, diarrhea, etc), metallic taste, hypoglycemia (rare)

Rare SE: lactic acidosis with kidney failure Nursing implications; give with meals. Glucophage

XR given once daily with evening meal. Glucophage must be stopped 48 hours before and after radiology studies that use iodine. Monitor renal function.

Page 41: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Alpha-Glucosidase Inhibitors Examples—acarbose, miglitol Action—lower blood sugar by delaying

carbohydrate digestion and absorption Adverse Reactions—bloating and

flatulence, abdominal pain, diarrhea Nursing considerations: given with first

bite of the meal because food increases absorption. Monitor liver function

Page 42: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Meglitinides Examples—nateglinide (Starlix), repaglinide

(Prandin) Action—stimulate insulin release from the

pancreas in response to a glucose load. Has short duration of action, thus reduces the potential for hypogylcemic reactions.

Adverse Reactions – upper respiratory infection (URI), headache, rhinitis, bronchitis, headache, back pain, hypoglycemia

Nursing considerations: give 15-30 minutes before meal. Disadvantage- need to take up to 4 doses a day

Page 43: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thiazolidinediones Examples—rosiglitazone (Avandia-December 2008,

FDA announced safety issues and increase of cardiac related deaths, off market), pioglitazone (Actos)

Action—decrease insulin resistance and increase insulin sensitivity by modifying several processes. . Increases sensitivity of muscle and fat tissue to insulin

Adverse Reactions—aggravated diabetes mellitus, URI, sinusitis, headache, pharyngitis, myalgia, diarrhea, back pain

Nursing considerations: delay of a meal for as little as 30 minutes can cause hypoglycemia. Monitor liver function. Reduces the blood level of some oral contraceptives

Page 44: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Combination Agents Metaglip- glipizide and metformin Glucovance-glyburide and metformin Actoplus Met- pioglitazone and

metformin Avandamet- rosiglitazone and metformin Duetact- Pioglitazone and glimepiride Avandaryl- rosiglitzone and glimepride

Page 45: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Pharmacologic Algorithm for Treating Type 2 Diabetes

See text, page 558

Page 46: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Emergency Medications to ELEVATE Glucose Glucagon IM (glucagon is a hormone

produced by the alpha cells of the pancreas-stimulates the conversion of glycogen to glucose in the liver. . return to consciousness within 5-20 minutes, if no response, suggests a lack of available hepatic glycogen and will need to administer IV dextrose)

IV D50

Page 47: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Key Concepts for Insulin Know which insulins can or cannot be mixed (Lantus cannot be

mixed) Concentration of U100 most commonly used Check expiration date, name, concentration each time Rotate cloudy suspensions Check orders/verify with 2nd nurse per agency protocol No air bubbles Rotate sites Familiarize self with needle size, pens, dials, pumps Hypoglycemic reactions can occur anytime, but most common

during insulin peak time Proper storage-room temperature if used within one month,

refrigerate up to 3 months Prefilled syringes are stable for one week Insulin needs change if stressed or ill Travel with supplies and snacks Know signs and symptoms of hyper and hypoglycemia

Page 48: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Case Study Timothy Jones is admitted to your unit

with a diagnosis of new onset type 1 diabetes mellitus. His blood sugars have stabilized and he is beginning to ask questions. How would you answer the following questions?

What is diabetes?Why can’t I be on pills instead of insulin?Why do I have to test my blood sugars?What should I do if it is too high or too

low?Does insulin have any side effects?

What should I watch for?

Page 49: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Develop a Care Plan for Mr. Jones, a 22 year old newly diagnosed with Type 1 diabetes

MD orders include: Test blood sugars ac and

hs Regular insulin sc

coverage ac and hs Sliding scale: < 200 no coverage 201-250---2 u 251-300---4 u 301-350---6 u 351-400---8 u > 400 Call MD

Humulin N 20 units sc 7:30 am

1800 ADA diet

Page 50: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Videos or Workbook Activities

Insulin Injections Novo Pen 3 Workbook, chapter 43

Page 51: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Review of Introduction

NCLEX and Pharmacology Generic names for medications, may

use brand name if only one brand name available

May give clues such as drug classification

May ask question(s) by drug classification

Page 52: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Core Concepts in PharmacologySecond Edition

Chapter 29

Drugs for Endrocrine Disorders

Norman Hollandand

Michael Patrick Adams

Page 53: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

The Endocrine System Consists of glands that secrete

hormones Hormones are released as changes in

the body occur Hormones are transported by the blood

through the body One hormone may control the secretion

of another hormone Hormone action is controlled by a

negative feedback mechanism

Page 54: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Utilization of Hormones Replacement therapy for patients

who are unable to secrete sufficient quantities of endogenous hormones Thyroid hormone - following a

thyroidectomy Insulin - when the pancreas is not

functioning Given in the same low-level amounts

as if secreted by the gland

Page 55: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Utilization of Hormones (cont’d) Cancer chemotherapy

Testosterone for breast cancer Estrogen for testicular cancer Given in doses much larger than normally

secreted by the gland Used to produce an exaggerated

response Hydrocortisone - suppress inflammation Estrogen or progesterone - prevent

ovulation and pregnancy

Page 56: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

The Hypothalamus and the Pituitary Gland Hypothalamus secretes releasing factors

(hormones) that travel by way of the blood to the anterior pituitary Releasing factors tell pituitary which hormone

to release Pituitary gland releases the appropriate

hormone into the blood, which travels to its target organ to cause its effect

Thyrotropin-releasing hormone (hypothalamus) Thyroid-stimulating hormone (pituitary gland) Thyroid hormone (thyroid gland-target organ)

Page 57: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Pancreas Essential to both the digestive and

endocrine systems Exocrine function - secretes several

enzymes into the duodenum via the pancreatic duct Assist in chemical digestion

Endocrine function - islets of Langerhans secrete glucagon and insulin directly into the blood

Page 58: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Secretion Regulated by a number of chemicals,

hormonal and nervous factors Glucose in the blood stimulates islets of

Langerhans in the pancreas to secrete insulin

Insulin affects carbohydrate, lipid, and protein metabolism

Without insulin glucose can’t enter the cells to be used for fuel

Page 59: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Glucagon

Secreted by the islets of Langerhans in the pancreas

Secreted when levels of glucose in the blood are low

Maintains adequate levels of glucose in the blood between meals

Moves glucose from liver to the blood

Page 60: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Type 1 Diabetes Mellitus Aka juvenile-onset diabetes Lack of insulin secretion by the pancreas Genetic component Signs and symptoms

Hyperglycemia Polyuria Polyphagia Polydipsia Glucosuria Weight loss Fatigue

Page 61: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Type 2 Diabetes Mellitus

Aka adult-onset diabetes Pancreas secretes insulin in small

amounts but insulin receptors in target cells insensitive or resistant to insulin

Common in overweight clients and those having low HDL-cholesterol and high triglyceride levels

Page 62: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Untreated Both Type 1 and Type 2 Can Produce Serious Long-Term Damage

To blood vessels in heart, brain, kidneys, eyes, legs, and feet

To peripheral nerves in hands and feet

Page 63: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Type 1 Diabetes - Treatment

Type 1 diabetes is treated with a combination of diet, exercise, and insulin Meals regularly, every 4–5 hours, to

regulate blood glucose levels Regular, moderate exercise to help

cells respond to insulin Insulin therapy to keep blood glucose

levels within normal limits

Page 64: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Type 2 Diabetes - Treatment

Controlled through lifestyle changes and oral hypoglycemic agents

Proper diet and exercise can sometimes increase sensitivity of insulin receptors

Page 65: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Type 2 Diabetes - Treatment (cont’d) Oral hypoglycemic drugs

When diet and exercise have failed to decrease the blood glucose

Five classes of oral hypoglycemics Classifications based on chemical structure

and mechanism of action Therapy initiated with a single agent Oral hypoglycemics are effective when

taken on a regular basis

Page 66: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drug Profile - Oral Hypoglycemic

Glipizide (Glucotrol), second generation sulfonylurea

Actions and uses Adverse effects and interactions Mechanism in action

Page 67: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Therapy

Five types of insulin available, differing in onset of action and duration of action

Page 68: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.2 Insulin Preparations

Page 69: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.2 (continued) Insulin Preparations

Page 70: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin Therapy (cont’d) Most insulin today obtained through

recombinant technology Routes of administration:

Most common route is subcutaneous Only regular insulin can be given IV Insulin pumps are being used Research to discover new routes - nasal spray

Doses of insulin highly individualized Self-monitoring of blood glucose is

important

Page 71: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drug Profile - Insulin

Regular insulin (Humulin R, Novolin R)

Actions and uses Adverse effects and interactions Mechanism in action

Page 72: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hypoglycemia Can Result From:

Insulin overdose Improper timing of insulin dose Skipping a meal

Page 73: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Signs and Symptoms of Hypoglycemia

Tachycardia Confusion Sweating Drowsiness Without quick treatment you will

see convulsions, coma, and death

Page 74: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hyperglycemia Can Result From: Underdose of insulin or hypoglycemic

agent Signs and symptoms of hyperglycemia

Fasting blood glucose greater than 126 mg/dl Polyuria Polyphagia Polydipsia Glucosuria Weight loss/gain Fatigue

Page 75: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thyroid

Follicular cells secrete thyroid hormones Thyroxine (tetraiodothyronine or T4) Triiodothyronine (T3) Iodine is necessary for the production of

these hormones Found in iodized salt

Parafollicular cells secrete calcitonin Involved with calcium homeostasis

Page 76: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thyroid Function

Multiple levels of hormonal control TRH stimulates the pituitary gland

to produce and secrete TSH TSH stimulates the thyroid gland to

produce and secrete thyroid hormones into the blood

Page 77: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thyroid Function (cont’d) When thyroid hormones reach a

certain level in the blood, the secretions of TRH and TSH are slowed down

This slowing down is known as a negative feedback loop

If thyroid hormone levels in the blood drop then more TRH and TSH will be secreted

Page 78: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thyroid Hormone Affects Every Cell in the Body

Regulates basal metabolic rate Critical to growth of the nervous

system

Page 79: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hypothyroidism

Causes of insufficient secretion of TSH or thyroid hormone Consequences of autoimmune

disease Surgical removal of thyroid gland Aggressive treatment with antithyroid

drugs

Page 80: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Types of Hypothyroidism

Cretinism - children Signs and symptoms of cretinism

Dwarfism Severe mental retardation Myxedema - adults

Myxedema - adults

Page 81: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Types of Hypothyroidism (cont’d) Signs and symptoms of myxedema

Slowed body metabolism Slurred speech Bradycardia, weight gain Low body temperature Intolerance to cold

Page 82: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Treatment for Both Types Is Natural or Synthetic Thyroid Hormone

Page 83: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hyperthyroidism - Too Much Thyroid Hormone Secreted

Graves’ disease - severe form of hyperthyroidism

Signs and symptoms Increased body metabolism Tachycardia, weight loss High body temperature Anxiety

Page 84: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hyperthyroidism - Treatment

Thyroidectomy if due to tumor Given antithyroid agents to kill or

inactivate some of the thyroid cells, sometimes before thyroidectomy to decrease bleeding during surgery

Ionizing radiation to kill or inactivate thyroid cells

Page 85: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Adrenal Gland

Cortex Medulla

Page 86: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Adrenal Cortex Secrete several classes of steroid

hormones Glucocorticoids Mineralocorticoids Androgens

The three hormones are referred to as corticosteroids or adrenocortical hormones

Page 87: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Mineralocorticoid

Aldosterone Increases the renal absorption of

sodium in exchange for potassium

Page 88: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Glucocorticoid

CRF secreted from the hypothalamus

Causes release of ACTH from the pituitary gland

Glucocorticoids are released from the adrenal cortex

As the glucocorticoid level rises, hormones are shut off

Page 89: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Glucocorticoids Affect Metabolism of Nearly Every Cell

During long-term stress, mobilize the formation of glucose

Increase the breakdown and utilization of proteins and lipids

Potent anti-inflammatory effect Promote homeostasis of the

cardiovascular, nervous, and musculoskeletal systems

Page 90: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Adrenocortical Insufficiency Decrease production of corticosteroid Causes

Hyposecretion by adrenal cortex Inadequate secretion of ACTH from pituitary

Signs and symptoms Hypoglycemia Fatigue Hypotension GI disturbances

Page 91: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Primary adrenocortical insufficiency - Addison’s Disease

Quite rare Deficiency of both glucocorticoids

and mineralocorticoids Treated with glucocorticoid

replacement therapy

Page 92: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Secondary Adrenocortical Insufficiency

Relatively common Long-term therapy with

glucocorticoids that is abruptly discontinued

Treated with glucocorticoid replacement therapy

Page 93: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Insulin

Page 94: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.2 Insulin Preparations

Page 95: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.2 (continued) Insulin Preparations

Page 96: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Oral Hypoglycemics

Page 97: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.3 Oral Hypoglycemics

Page 98: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.3 (continued) Oral Hypoglycemics

Page 99: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.3 (continued) Oral Hypoglycemics

Page 100: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Thyroid and Antithyroid Agents

The correct dose is highly individualized

Requires periodic adjustments

Page 101: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Table 29.4 Thyroid and Antithyroid Medications

Page 102: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hypothyroidism Slows the Body’s Metabolism

Administration of thyroid hormone reverses that effect

Page 103: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drug Profile - Thyroid Agent

Levothyroxine (Synthroid) Actions and uses Adverse effects and interactions Mechanism in action

Page 104: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Hyperthyroidism Speeds the Body’s Metabolism

Administer drugs that kill or inactivate thyroid cells

Page 105: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drug Profile - Antithyroid Agent

Propylthiouracil (Propacil) Actions and uses Adverse effects and interactions Mechanism in action

Page 106: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Glucocorticoids Are Used to Treat: Inflammatory and immune responses Disorders that may be treated with

corticosteroids Allergies, seasonal rhinitis, asthma Contact dermatitis and rashes Hodgkin’s disease, leukemias, lymphomas Shock Rheumatoid arthritis, ankylosing spondylitis, bursitis Ulcerative colitis, Crohn’s disease Hepatic, neurological, renal disorders with edema Following transplant surgery

Page 107: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Significant Adverse Effects Can Occur During Long-Term Therapy

Known as Cushing’s Syndrome Adrenal atrophy Osteoporosis Increased risk of infections Delayed wound healing Peptic ulcer Accumulation of fat around shoulders and

neck Mood and personality changes

Page 108: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Drug Profile - Glucocorticoid

Hydrocortisone (Cortef) Actions and uses Adverse effects and interactions Mechanism in action

Page 109: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Growth Hormone - Aka Somatotropin

Secreted by pituitary gland Stimulates growth of cell Deficiency in children Dwarfism with no mental

impairment

Page 110: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Growth Hormone Medications for Dwarfism in Children

Somatrem (Protopin) Somatropin (Humantrope) Not approved to stimulate growth

in short children

Page 111: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Antidiuretic Hormone

Produced by the hypothalamus Secreted from the posterior pituitary

gland Increases water absorption by kidneys Raises blood pressure if secreted in

large amounts Diabetes insipidus - deficiency of ADH

Page 112: Chapter 43 Antidiabetic Drugs Revised 11/10. Diabetes A complicated, chronic disorder characterized by insufficient insulin production or by cellular

Treatment of Diabetes Insipidus

Vasopressin (Pitressin) Desmopressin (DDAVP, Stimate) Lopressin (Diapid) Desmopressin used for enuresis -

nasal spray